Hm Payson & CO Enovis Corp Transaction History

Hm Payson & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 20, 2024	SELL	$55.44 - $63.8 $9,203 - $10,590	-166 Reduced 95.4%	8 $0
Q2 2023 Jul 17, 2023	SELL	$52.7 - $64.12 $4,479 - $5,450	-85 Reduced 32.82%	174 $11,000
Q1 2023 Apr 18, 2023	SELL	$49.5 - $65.92 $711,315 - $947,270	-14,370 Reduced 98.23%	259 $13,000
Q4 2022 Feb 06, 2023	SELL	$44.83 - $57.43 $146,504 - $187,681	-3,268 Reduced 18.26%	14,629 $782,000
Q3 2022 Oct 25, 2022	SELL	$46.07 - $60.1 $707,543 - $923,015	-15,358 Reduced 46.18%	17,897 $825,000
Q2 2022 Aug 15, 2022	BUY	$55.0 - $70.47 $1.83 Million - $2.34 Million	33,255 New	33,255 $1.83 Million

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.